Lv2
130 积分 2025-07-24 加入
Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70‑mediated lysosomal degradation of EGFR in EGFR‑mutant lung adenocarcinoma
10天前
已完结
Molecular docking, pharmacokinetic and molecular simulation analysis of novel mono-carbonyl curcumin analogues as L858R/T790M/C797S mutant EGFR inhibitors
10天前
已完结
Osimertinib in Untreated EGFR‑Mutated Advanced Non‑Small‑Cell Lung Cancer
10天前
已完结
Current treatment strategies for EGFR‑mutated non‑small cell lung cancer from first line to beyond osimertinib resistance
10天前
已完结
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor‑Mutated Lung Cancer: Personalization, Parsimony, and Partnership
11天前
已完结
Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC)
11天前
已完结
Plasmonic gold-titania-curcumin nanoantennas for synergistic quadruple photodynamic/mild photothermal/radiodynamic/chemotherapy of non-small cell lung cancer
16天前
已完结
First‑line systemic chemotherapy in the treatment of advanced non‑small cell lung cancer: a systematic review
21天前
已关闭
Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing
1个月前
已完结
皖公网安备34019202002308
